Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: More Movement on the 336 - still here Opty

In your post, you suggest that it might be possible for the examiner and PTO to just simply terminate the reexam. Perfect....then our position would simply fall back onto the already published NIRC. I had assumed our options would be an office action or possibly another intent to issue a NIRC. It sounds simple . I wonder if this is scenario meets USPTO rules and guidelines. It would be awesome imo and the stock might rock! good luck

Share
New Message
Please login to post a reply